Although these data may imply a role for DGKA and DGKH in AML pathogenesis, they should be interpreted with the utmost caution, as it is challenging to identify a suitable “healthy reference tissue” for a disease like AML, which affects cell differentiation. This evidence concerns the gene DGKA and acute myeloid leukemia.